Suppr超能文献

医疗补助扩张状况和种族对黑色素瘤患者诊断时转移性疾病的影响。

Impact of Medicaid Expansion Status and Race on Metastatic Disease at Diagnosis in Patients with Melanoma.

机构信息

University of Florida Health Cancer Center, University of Florida, 1600 SW Archer Road, D2-3, Gainesville, FL, 32610, USA.

Billings Clinic, 2800 Tenth Avenue North, Billings, MT, 59107, USA.

出版信息

J Racial Ethn Health Disparities. 2022 Dec;9(6):2291-2299. doi: 10.1007/s40615-021-01166-6. Epub 2021 Oct 14.

Abstract

BACKGROUND

Black patients are diagnosed with melanoma at a later stage, as compared with their white counterparts. It is unknown if Medicaid expansion might ameliorate this disparity.

METHODS

Using data from the 2016 National Cancer Database, we conducted a retrospective cohort study. The primary objective was to evaluate whether being diagnosed with melanoma at a Medicaid Expansion State (MES) and black race are associated with a late diagnosis of melanoma.  Main exposure: Being diagnosed in a MES. Secondary exposure: Race. Main outcome: Odds of Stage IV vs Stages 0-III at diagnosis. Univariate, multivariate logistic regression, and propensity score analyses were conducted to evaluate the potential associations. Sub-group analysis was conducted according to age < 65 or ≥ 65 years.

RESULTS

A total of 216,604 patients were included, 40-90 years of age, [Formula: see text] 64 years [SD 12.47]. In univariate analysis, patients diagnosed in MES were 15% less likely (95% CI, 0.81-0.88) to be diagnosed with Stage IV melanoma. Black race (vs white) had 3.04 increased odds (95% CI, 2.56-3.60) of late diagnosis. In multivariate analysis, adjusting for socio-economic confounders, patients < 65 years of age were 13% less likely (95% CI, 0.82-0.92) to be diagnosed with Stage IV melanoma. By propensity score analysis, the strength of the associations remained. Black race (vs white) was associated with higher odds (95% CI, 1.91-3.08) of being diagnosed with Stage IV disease. For black patients < 65 years, being diagnosed in a state without Medicaid expansion had 2.55 higher odds (95% CI, 1.93-3.38) of being diagnosed with Stage IV melanoma, which decreased to 2.11 odds (95% CI, 1.34-3.33) in MES. The interaction between race and MES was statistically significant (P = 0.008).

CONCLUSIONS

This study suggests that patients are less likely to be diagnosed with Stage IV melanoma in MES. This beneficial effect is more pronounced among Black minorities.

摘要

背景

与白人患者相比,黑种人患者的黑色素瘤确诊时间更晚。尚不清楚医疗补助扩展计划是否可以改善这一差距。

方法

本研究使用了 2016 年国家癌症数据库的数据,开展了一项回顾性队列研究。主要目的是评估在医疗补助扩大州(MES)诊断黑色素瘤和黑种人种族是否与黑色素瘤的晚期诊断相关。主要暴露因素:在 MES 中诊断。次要暴露因素:种族。主要结局:诊断时 IV 期与 0-III 期的比值。进行单变量、多变量逻辑回归和倾向评分分析,以评估潜在关联。根据年龄<65 岁或≥65 岁进行亚组分析。

结果

共纳入 216604 名 40-90 岁的患者[公式:见正文]64 岁[标准差 12.47]。在单变量分析中,MES 中诊断的患者 IV 期黑色素瘤的诊断可能性降低 15%(95%CI,0.81-0.88)。与白人相比,黑种人(vs 白人)的晚期诊断风险增加了 3.04 倍(95%CI,2.56-3.60)。在多变量分析中,调整了社会经济混杂因素后,年龄<65 岁的患者 IV 期黑色素瘤的诊断可能性降低了 13%(95%CI,0.82-0.92)。通过倾向评分分析,关联的强度仍然存在。与白人相比,黑种人(vs 白人)的 IV 期疾病诊断风险更高(95%CI,1.91-3.08)。对于年龄<65 岁的黑人患者,在没有医疗补助扩展计划的州诊断,IV 期黑色素瘤的诊断可能性增加了 2.55 倍(95%CI,1.93-3.38),在 MES 中,这一几率降至 2.11 倍(95%CI,1.34-3.33)。种族和 MES 之间的交互作用具有统计学意义(P=0.008)。

结论

本研究表明,在 MES 中,患者 IV 期黑色素瘤的诊断可能性较低。这一有益效果在黑人群体中更为明显。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验